Clinicians must understand the treatment evolution and guidelines for when to administer two-, three-, or four drug regimens as initial or subsequent therapy in context of the patient's therapeutic and disease history. In addition, it is important for clinicians to educate patients about their different treatment options (e.g., administration and adverse events) and discuss patient preferences and individual circumstances that may affect treatment recommendations.

It is critically important for oncology care providers to be aware of the best ways to incorporate these advances into standard practice so that each patient can receive optimal care.

It is important for physicians to stay up to date on treatment recommendations so they can best evaluate available data and select the optimal therapeutic strategy based on the patient’s clinical needs. 

The goal of this program is to improve the knowledge and competence of learners in the optimal management of patients with CLL/SLL.